摘要 |
The present disclosure relates to compounds of Formula (1),
compositions and methods for the treatment of hepatitis C virus (HCV) infection. Also disclosed are pharmaceutical compositions containing such compounds and compounds of Formula (1) for use in a method of treating an HCV infection. |